InsiderTrades

Rosen David Efraim

SEC CIK 1898677 · EDGAR

Buying vs selling by month open-market trades, last 51 months, all 3 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
HRTXHERON THERAPEUTICS, INC. /DE/10% 30.05M $3.58M — 22025-08-082025-10-15
TLNTalen Energy Corp10% 6.48M — $999.99M 22024-12-132024-12-13
TXMDTherapeuticsMD, Inc.Dir, 10%, See Remarks 2.95M $15.58M — 52022-07-152023-11-15

Most active insiders at HRTX, 12 months

#InsiderTitleBoughtSold
1 Cusack ThomasDir ——
2 Hensley Mark EarlCOO ——
3 Morgan AdamDir ——
4 Rosen David Efraim10% ——
5 Dissanaike SharmilaDir ——
6 Kaseta MichaelDir ——
7 Christian WaageDir ——
8 Duarte IraEVP, CFO ——
9 Johnson Craig ADir ——
10 Collard Craig ACEO, Dir ——

Transactions 9

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
DI 2025-10-17 2025-10-15 HRTX HERON THERAPEUTICS, INC. /DE/ Rosen David Efraim 10% C - Cnv Deriv — +946.1K 30.05M +3% —
DI 2025-08-12 2025-08-08 HRTX HERON THERAPEUTICS, INC. /DE/ Rosen David Efraim 10% P - Purchase $1.50 +2.39M 29.10M +9% +$3.58M
I 2024-12-16 2024-12-13 TLN Talen Energy Corp Rosen David Efraim 10% S - Sale $204.35 -4.89M 6.48M -43% -$999.99M
I 2024-12-16 2024-12-13 TLN Talen Energy Corp Rosen David Efraim 10% J - Other — -351.6K 6.12M -5% —
I 2023-11-17 2023-11-15 TXMD TherapeuticsMD, Inc. Rosen David Efraim 10% A - Grant $2.28 +877.2K 2.95M +42% +$2.00M
I 2023-06-29 2023-06-28 TXMD TherapeuticsMD, Inc. Rosen David Efraim Dir, 10%, See Remarks A - Grant $3.68 +312.5K 2.07M +18% +$1.15M
MI 2022-12-09 2022-12-07+ TXMD TherapeuticsMD, Inc. Rosen David Efraim 10% P - Purchase $5.66 +20.4K 1.74M +1% +$115.6K
MI 2022-08-01 2022-07-29 TXMD TherapeuticsMD, Inc. Rosen David Efraim 10% P - Purchase $25.86 +580.0K 1.72M +51% +$15.00M
MI 2022-07-19 2022-07-15+ TXMD TherapeuticsMD, Inc. Rosen David Efraim 10% P - Purchase $5.66 +82.6K 1.16M +8% +$467.5K

Purchase Sale Sale after option exercise All abbreviations